Adriana Boateng-Kuffour, PhD, MS, MPH·Sep 23When Does Real-World Evidence Become Decision-Grade Evidence?Real-world evidence has become central to healthcare decision-making. It informs clinical development, market access, reimbursement, health…
InZS AssociatesbySarah Jegasothy·May 14Most-Favored Nation Impact on APAC RegionWhy APAC matters more now
InZS AssociatesbySarah Jegasothy·Apr 13Pre‑approval access in APAC: Designing early access as a bridge to sustainable patient careAPAC pre-approval access should be designed as a bridge to approval, built on readiness, clear transitions and full-pathway support.
InZS AssociatesbySuman Sen·Feb 16Redefining best-in-class Access Strategy and Marketing capabilitiesHow manufacturers can boost their Access Strategy and Marketing team by adopting structured, data-driven and customer-focused strategies in…
Nathan Sigworth·Sep 21, 2023The practical guide to digitizing market accessAs getting new medicines to market becomes more complex, market access leaders across pharma, payer and HTA organizations are beginning to…
